vs
Side-by-side financial comparison of CENTURY ALUMINUM CO (CENX) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
CENTURY ALUMINUM CO is the larger business by last-quarter revenue ($633.7M vs $493.8M, roughly 1.3× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 0.3%, a 6.5% gap on every dollar of revenue. On growth, CENTURY ALUMINUM CO posted the faster year-over-year revenue change (0.4% vs -1.7%). Over the past eight quarters, CENTURY ALUMINUM CO's revenue compounded faster (13.8% CAGR vs -0.1%).
Century Aluminum Company is a US-based producer of primary aluminum, with aluminum plants in Kentucky, South Carolina and Iceland. It is the largest producer of primary aluminum in the United States. The company is a publicly held corporation listed on the NASDAQ. The headquarters is at One South Wacker in Chicago.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
CENX vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $633.7M | $493.8M |
| Net Profit | $1.8M | $33.7M |
| Gross Margin | 13.0% | — |
| Operating Margin | 5.2% | 9.9% |
| Net Margin | 0.3% | 6.8% |
| Revenue YoY | 0.4% | -1.7% |
| Net Profit YoY | -96.0% | 10.5% |
| EPS (diluted) | $0.03 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $633.7M | $493.8M | ||
| Q3 25 | $632.2M | $492.9M | ||
| Q2 25 | $628.1M | $468.8M | ||
| Q1 25 | $633.9M | $458.4M | ||
| Q4 24 | $630.9M | $502.4M | ||
| Q3 24 | $539.1M | $511.2M | ||
| Q2 24 | $560.8M | $504.3M | ||
| Q1 24 | $489.5M | $495.1M |
| Q4 25 | $1.8M | $33.7M | ||
| Q3 25 | $14.9M | $71.7M | ||
| Q2 25 | $-4.6M | $39.3M | ||
| Q1 25 | $29.7M | $20.7M | ||
| Q4 24 | $45.2M | $30.5M | ||
| Q3 24 | $47.3M | $19.4M | ||
| Q2 24 | $-2.5M | $-153.0M | ||
| Q1 24 | $246.8M | $4.0M |
| Q4 25 | 13.0% | — | ||
| Q3 25 | 12.2% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 9.6% | — | ||
| Q4 24 | 10.5% | — | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 3.6% | — | ||
| Q1 24 | 3.4% | — |
| Q4 25 | 5.2% | 9.9% | ||
| Q3 25 | 9.2% | 13.8% | ||
| Q2 25 | 3.3% | 12.8% | ||
| Q1 25 | 7.3% | 7.0% | ||
| Q4 24 | 7.8% | 7.8% | ||
| Q3 24 | 11.8% | 6.6% | ||
| Q2 24 | 1.1% | -31.3% | ||
| Q1 24 | 0.4% | 3.2% |
| Q4 25 | 0.3% | 6.8% | ||
| Q3 25 | 2.4% | 14.5% | ||
| Q2 25 | -0.7% | 8.4% | ||
| Q1 25 | 4.7% | 4.5% | ||
| Q4 24 | 7.2% | 6.1% | ||
| Q3 24 | 8.8% | 3.8% | ||
| Q2 24 | -0.4% | -30.3% | ||
| Q1 24 | 50.4% | 0.8% |
| Q4 25 | $0.03 | $0.40 | ||
| Q3 25 | $0.15 | $0.84 | ||
| Q2 25 | $-0.05 | $0.46 | ||
| Q1 25 | $0.29 | $0.24 | ||
| Q4 24 | $0.58 | $0.37 | ||
| Q3 24 | $0.46 | $0.23 | ||
| Q2 24 | $-0.03 | $-1.84 | ||
| Q1 24 | $2.26 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $134.2M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $805.6M | $865.9M |
| Total Assets | $2.3B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $134.2M | $375.2M | ||
| Q3 25 | $151.4M | $340.1M | ||
| Q2 25 | $40.7M | $224.7M | ||
| Q1 25 | $44.9M | $99.0M | ||
| Q4 24 | $32.9M | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | $41.3M | $19.4M | ||
| Q1 24 | $93.5M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $805.6M | $865.9M | ||
| Q3 25 | $741.8M | $890.7M | ||
| Q2 25 | $724.4M | $833.8M | ||
| Q1 25 | $726.3M | $789.2M | ||
| Q4 24 | $694.4M | $764.9M | ||
| Q3 24 | $628.5M | $732.5M | ||
| Q2 24 | $601.5M | $706.5M | ||
| Q1 24 | $601.5M | $856.2M |
| Q4 25 | $2.3B | $2.2B | ||
| Q3 25 | $2.1B | $2.2B | ||
| Q2 25 | $1.9B | $2.1B | ||
| Q1 25 | $2.0B | $2.0B | ||
| Q4 24 | $1.9B | $2.2B | ||
| Q3 24 | $2.1B | $2.1B | ||
| Q2 24 | $1.8B | $2.0B | ||
| Q1 24 | $1.8B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $102.8M | $114.1M |
| Free Cash FlowOCF − Capex | $67.7M | — |
| FCF MarginFCF / Revenue | 10.7% | — |
| Capex IntensityCapex / Revenue | 5.5% | — |
| Cash ConversionOCF / Net Profit | 57.11× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $84.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $102.8M | $114.1M | ||
| Q3 25 | $2.0M | $137.3M | ||
| Q2 25 | $7.9M | $137.2M | ||
| Q1 25 | $72.3M | $-117.5M | ||
| Q4 24 | $-41.4M | $133.0M | ||
| Q3 24 | $20.1M | $91.8M | ||
| Q2 24 | $11.5M | $107.0M | ||
| Q1 24 | $-14.8M | $-125.2M |
| Q4 25 | $67.7M | — | ||
| Q3 25 | $-18.1M | — | ||
| Q2 25 | $-15.9M | — | ||
| Q1 25 | $51.1M | — | ||
| Q4 24 | $-54.6M | — | ||
| Q3 24 | $-2.4M | — | ||
| Q2 24 | $-5.4M | — | ||
| Q1 24 | $-44.5M | — |
| Q4 25 | 10.7% | — | ||
| Q3 25 | -2.9% | — | ||
| Q2 25 | -2.5% | — | ||
| Q1 25 | 8.1% | — | ||
| Q4 24 | -8.7% | — | ||
| Q3 24 | -0.4% | — | ||
| Q2 24 | -1.0% | — | ||
| Q1 24 | -9.1% | — |
| Q4 25 | 5.5% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 4.2% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 6.1% | — |
| Q4 25 | 57.11× | 3.39× | ||
| Q3 25 | 0.13× | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | 2.43× | -5.66× | ||
| Q4 24 | -0.92× | 4.36× | ||
| Q3 24 | 0.42× | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.06× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CENX
| Aluminum | $566.3M | 89% |
| Alumina | $67.4M | 11% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
